Elevation of Intact Parathyroid Hormone Level Is a Risk Factor for Low Bone Mineral Density in Pretransplant Patients With Liver Diseases

Transplantation Proceedings

Volumn 39, Issue 10, 2007, Pages 3182-3185

  Bai, X L ^a   Liang, T B ^a   Wu, L H ^a   Li, D L ^a   Geng, L ^a   Wang, W L ^a   Shen, Y ^a   Zhang, M ^a   Zheng, S S ^a  

^a BEIJING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE BONE ISOENZYME; CALCIUM; CREATININE; DEOXYPYRIDINOLINE; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CALCIUM BLOOD LEVEL; CHOLESTASIS; CREATININE URINE LEVEL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; TREATMENT INDICATION; VITAMIN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; BONE DENSITY; BONE DISEASES, METABOLIC; CHOLESTASIS; FEMALE; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OSTEOPOROSIS; PARATHYROID HORMONE; PREOPERATIVE CARE; RISK FACTORS; WAITING LISTS;

EID: 37149047460     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.06.093     Document Type: Article

References (21)

1. Leidig-Bruckner G., Hosch S., Dodidou P., et al. Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet 357 (2001) 342
2. Crippin J.S. Bone disease after liver transplantation. Liver Transpl 7 (2001) S27
3. Monegal A., Navasa M., Guanabens N., et al. Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos Int 12 (2001) 484
4. Hay J.E. Osteoporosis in liver diseases and after liver transplantation. J Hepatol 38 (2003) 856
5. Carey E.J., Balan V., Kremers W.K., et al. Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: not just a cholestatic problem. Liver Transpl 9 (2003) 1166
6. Guichelaar M.M., Malinchoc M., Sibonga J., et al. Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry. Hepatology 36 (2002) 895
7. Bagur A., Mautalen C., Findor J., et al. Risk factors for the development of vertebral and total skeleton osteoporosis in patients with primary biliary cirrhosis. Calcif Tissue Int 63 (1998) 385
8. Monegal A., Navasa M., Guanabens N., et al. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 60 (1997) 148
9. Crosbie O.M., Freaney R., McKenna M.J., et al. Bone density, vitamin D status, and disordered bone remodeling in end-stage chronic liver disease. Calcif Tissue Int 64 (1999) 295
10. Sokhi R.P., Anantharaju A., Kondaveeti R., et al. Bone mineral density among cirrhotic patients awaiting liver transplantation. Liver Transpl 10 (2004) 648
11. Crawford B.A., Kam C., Donaghy A.J., et al. The heterogeneity of bone disease in cirrhosis: a multivariate analysis. Osteoporos Int 14 (2003) 987
12. Ormarsdóttir S., Ljunggren o., Mallmin H., et al. Low body mass index and use of corticosteroids, but not cholestasis, are risk factors for osteoporosis in patients with chronic liver disease. J Hepatol 31 (1999) 84
13. Floreani A., Mega A., Camozzi V., et al. Is osteoporosis a peculiar association with primary biliary cirrhosis?. World J Gastroenterol 11 (2005) 5347
14. Trautwein C., Possienke M., Schlitt H.J., et al. Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation. Am J Gastroenterol 95 (2000) 2343
15. Schiefke I., Fach A., Wiedmann M., et al. Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 11 (2005) 1843
16. Duarte M.P., Farias M.L.F., Coelho H.S.M., et al. Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease. J Gastroenterol Hepatol 16 (2001) 1022
17. Raisz L.G. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115 (2005) 3318
18. Hernandez J.D., Wesseling K., and Salusky I.B. Role of parathyroid hormone and therapy with active vitamin D sterols in renal osteodystrophy. Semin Dial 18 (2005) 290
19. Goodman W.G. Calcimimetics: a remedy for all problems of excess parathyroid hormone activity in chronic kidney disease?. Curr Opin Nephrol Hypertens 14 (2005) 355
20. Rouiliard S., and Lane N.E. Hepatic osteodystrophy. Hepatology 33 (2001) 301
21. Collier J.D., Ninkovic M., and Compston J.E. Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 50 suppl 1 (2002) i1